Nous utilisons des cookies pour offrir aux visiteurs de notre site web la meilleure expérience possible. Si vous continuez sans changer les paramètres de votre navigateur, nous supposerons que vous êtes heureux de recevoir tous les cookies sur le site web de BioTek. Pour en savoir plus concernant notre utilisations de nos cookies ou comment faire pour bloquer, veuillez consulter notre politique, visite notre cookie policy.

Resources - Webinaires

Improving Cell-Based Drug Absorption Assays through the use of Cost-effective Automation and High-Density Permeable Support Systems

Related Products: Synergy H1

May 31, 2012

Presenters: Brad Larson, BioTek Instruments, Winooski, VT; Mark Rothenberg, Corning Incorporated, Kennebunk, ME

Corning

Cell-based drug absorption assays, using cell lines such as Caco-2 and MDCK-MDR1, are an essential component of lead compound ADME/Tox testing. Current methods typically incorporate 24-well microplates and are performed manually. Yet the need to generate absorption data earlier in the drug discovery process, on an increasing number of compounds, is driving the use of higher density plates. A simple, more efficient process that incorporates 96-well Transwell® Permeable Supports and proper instrumentation in an automated process provides more reproducible data compared to manual methods. We will demonstrate the ability to perform drug permeability and transport assays using Caco-2 or MDCKII-MDR1 cells in an automated 96-well format. All steps in the process, including cell and media dispensing, media exchanges, buffer washes, and compound transfers were able to be performed in a sterile manner using instrumentation that fits easily into existing laminar flow hoods.

 Click here to watch this webinar recording.

 

link